Proactive Investors - Run By Investors For Investors

Chemistree says cannabis licensee partner in Washington State has 18 Sugarleaf strains

The Sugarleaf brand will soon launch its own line of cannabis oil-based products to be dispensed in the Vapor Slide V2, a hybrid of a pen and dab
Cannabis in a greenhouse
The Sugarleaf brand has nine major cannabis strains and nine minor strains in smaller-batch production

Chemistree Technology Inc (CSE:CHM) (OTCMKTS:CHMJF) said Tuesday that its Sugarleaf brand in Washington State has 18 different strains of high-quality cannabis being grown in rotation, including nine major strains and nine minor strains in smaller-batch production.

The Vancouver-based cannabis-investment company said in a press release that the brand will soon launch its own line of cannabis oil-based products to be dispensed in the Sugarleaf-branded Vapor Slide V2, a hybrid of a pen and a dab, which is a device that provides a more intense delivery of THC.

READ: Chemistree Technology says common shares now eligible for electronic clearing in the US

The launch is Sugarleaf’s first foray into the concentrates market. Chemistree said there are plans to expand the Sugarleaf brand into other products and devices by the end of the first quarter of 2019.

Shares of Chemistree traded at C$0.57 in Monday’s Canadian trading. They climbed US$0.04 to US$0.41 on the OTC Markets.

Last week, Joel Hradecky, host of the YouTube channel CustomGrow420, led a video walkthrough of the Sugarleaf operation with an examination of strains under cultivation and an interview with Chemistree Chairman Justin Chorbajian. In addition, Chemistree said its common shares are now eligible for electronic clearing and settlement through the Depository Trust Co in the United States.

 

Contact Dennis Fitzgerald at [email protected]

 

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full CHM profile View Profile

Chemistree Technology Inc. Timeline

Related Articles

medical cannabis concept
February 10 2019
AusCann is a fully integrated early-mover pharmaceutical cannabinoid company.
cannabis flower
April 26 2019
The company's footprint continues to grow as it focuses on becoming a globally recognized house of brands with a broad portfolio of clients across North America
Empower clinic locations
March 26 2019
Empower Clinics is one of the largest operators of medical-cannabis-focused healthcare in the US
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use